Enzyme Cleavage Detection via Hidden Binding Site Reveal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for detecting protease activity, particularly at low concentrations in samples like urine, lack sufficient sensitivity and specificity, making it difficult to accurately diagnose conditions associated with protease activity.

Innovation Solution

The use of binding molecules that specifically bind to products of cleavage but not to the uncleaved indicator molecule, combined with a flow device design that allows for excess reagents without impacting specificity, enables the detection of protease activity at low concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional detection methods are used, then the detection process is simple, but sensitivity and specificity are insufficient for detecting low concentrations of protease activity

Engineering Contradiction:
Improvedetection sensitivity and specificityVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The indicator molecule is divided into distinct functional regions: a capture site for immobilization and a cleavage region with specific protease recognition sequences. This segmentation allows the detection system to separately handle sample preparation and enzymatic reaction, improving both sensitivity and ease of use.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

An indicator molecule serves as an intermediary between the protease enzyme and the detection system. The indicator molecule contains a cleavage region that specifically reacts with the target protease, converting enzymatic activity into a detectable signal through subsequent binding of detection antibodies to the cleaved product.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If binding molecules are used that specifically bind to cleavage products, then detection specificity is improved, but the assay requires additional reagents and steps

Engineering Contradiction:
Improvedetection specificityVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The indicator molecule serves multiple functions: it acts as a substrate for the target protease, provides a capture site for immobilization, and generates a detectable signal through cleavage. This multi-functionality reduces the need for separate reagents and simplifies the overall assay procedure while maintaining high specificity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The cleaved indicator molecule automatically provides binding sites for detection antibodies without requiring additional modification or processing steps. The protease cleavage event itself creates the epitope that the detection antibody recognizes, making the system self-sufficient and reducing procedural complexity.

Inventive Principle:
Principle #25Self-service

3Measurement precision

If excess reagents are used in the flow device, then detection sensitivity is enhanced, but reagent consumption and cost increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidreagent consumption
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The indicator molecule is pre-immobilized on the flow device substrate at optimized concentrations before sample application. This preliminary preparation ensures that when excess reagents (sample, detection antibodies) are introduced, they immediately interact with sufficient indicator molecules, enhancing sensitivity while allowing the immobilized indicator to serve as a fixed reference point that does not contribute to consumption variability.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for diagnostically useful results in detecting protease activity, particularly in urine samples, by enhancing sensitivity and specificity, and is applicable for diagnosing respiratory conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis.

Implementation Method 1

binding molecules capable of binding to the indicator molecule following cleavage, wherein the binding molecule is incapable of binding to the indicator molecule unless and until cleavage has occurred

Methodology Applied
Scientific EffectAntigen-antibody binding:

Implementation Method 2

an indicator molecule for adding to the test sample, the indicator molecule comprising a peptide having a sequence of amino acids comprising at least one peptide bond representing a protease cleavage site

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Data Source

PatentUS12320804B2Detection of cleavage activity of an enzyme
Publication Date: 2025.06.03 MOLOGIC LTD
  • US12320804B2 patent drawing
  • US12320804B2 patent drawing
  • US12320804B2 patent drawing

AI summary

The present invention relates to detecting cleavage activity of an enzyme. The various aspects of the invention include an enzyme detection device, kit, method and use for detecting or measuring the presence in a test sample of the activity of an enzyme capable of cleaving a substrate. The invention also relates to indicator and binding molecules useful for carrying out the invention. The enzyme substrate contains a hidden binding site which is only revealed upon cleavage by the enzyme.